Prosecution Insights
Last updated: August 16, 2026

Amano Enzyme Europe Ltd.

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)3 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BEKKER, KELLY JO 1 16.6% +35.2%
JACOBSON, MICHELE LYNN 1 26.6% +32.4%
MERRIAM, ANDREW E 1 25.0% +32.1%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18252518 METHOD FOR PRODUCING PROCESSED PLANT-BASED PROTEIN-CONTAINING LIQUID COMPOSITION BEKKER, KELLY JO 126d overdue
18042515 PLANT MILK TREATED WITH PROTEIN DEAMIDASE JACOBSON, MICHELE LYNN 46d overdue
17433072 PREVENTION OF AGGREGATION IN PLANT MILK MERRIAM, ANDREW E

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18252518 METHOD FOR PRODUCING PROCESSED PLANT-BASED PROTEIN-CONTAINING LIQUID COMPOSITION BEKKER, KELLY JO 126d overdue
18042515 PLANT MILK TREATED WITH PROTEIN DEAMIDASE JACOBSON, MICHELE LYNN 46d overdue
17433072 PREVENTION OF AGGREGATION IN PLANT MILK MERRIAM, ANDREW E

Top Art Units

Art UnitApps
1792 1
1793 1
1791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18252518 METHOD FOR PRODUCING PROCESSED PLANT-BASED PROTEIN-CONTAINING LIQUID COMPOSITION BEKKER, KELLY JO 1792 §103§112 Non-Final OA 126d overdue Pending May 10, 2023
18042515 PLANT MILK TREATED WITH PROTEIN DEAMIDASE JACOBSON, MICHELE LYNN 1793 §102§112 Final Rejection 46d overdue Pending Feb 22, 2023
17433072 PREVENTION OF AGGREGATION IN PLANT MILK MERRIAM, ANDREW E 1791 §103§112 Non-Final OA Pending Aug 23, 2021

Managing Amano Enzyme Europe Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month